Data_Sheet_1_A Peptide Vaccine Candidate Tailored to Individuals' Genetics Mimics the Multi-Targeted T Cell Immunity of COVID-19 Convalescent Subjects.docx
Long-term immunity to coronaviruses likely stems from T cell activity. We present here a novel approach for the selection of immunoprevalent SARS-CoV-2-derived T cell epitopes using an in silico cohort of HLA-genotyped individuals with different ethnicities. Nine 30-mer peptides derived from the four major structural proteins of SARS-CoV-2 were selected and included in a peptide vaccine candidate to recapitulate the broad virus-specific T cell responses observed in natural infection. PolyPEPI-SCoV-2-specific, polyfunctional CD8+ and CD4+ T cells were detected in each of the 17 asymptomatic/mild COVID-19 convalescents' blood against on average seven different vaccine peptides. Furthermore, convalescents' complete HLA-genotype predicted their T cell responses to SARS-CoV-2-derived peptides with 84% accuracy. Computational extrapolation of this relationship to a cohort of 16,000 HLA-genotyped individuals with 16 different ethnicities suggest that PolyPEPI-SCoV-2 vaccination will likely elicit multi-antigenic T cell responses in 98% of individuals, independent of ethnicity. PolyPEPI-SCoV-2 administered with Montanide ISA 51 VG generated robust, Th1-biased CD8+, and CD4+ T cell responses against all represented proteins, as well as binding antibodies upon subcutaneous injection into BALB/c and hCD34+ transgenic mice modeling human immune system. These results have implications for the development of global, highly immunogenic, T cell-focused vaccines against various pathogens and diseases.
History
References
- https://doi.org//10.3390/v12030254
- https://doi.org//10.12688/wellcomeopenres.15922.1
- https://doi.org//10.1126/sciimmunol.abd6160
- https://doi.org//10.1056/NEJMoa2028436
- https://doi.org//10.1007/s10875-011-9632-5
- https://doi.org//10.1093/infdis/jit319
- https://doi.org//10.1038/d41586-021-00121-z
- https://doi.org//10.1128/JVI.01505-14
- https://doi.org//10.1007/s12026-014-8534-z
- https://doi.org//10.1093/nar/gky1049
- https://doi.org//10.1038/s41598-020-70864-8
- https://doi.org//10.1038/s41577-020-00480-0
- https://doi.org//10.1126/science.abf4063
- https://doi.org//10.3389/fimmu.2020.00827
- https://doi.org//10.1038/s41591-020-01194-5
- https://doi.org//10.1016/j.immuni.2020.10.006
- https://doi.org//10.1038/s41418-020-00720-9
- https://doi.org//10.1093/nar/gkz1029
- https://doi.org//10.1016/j.humimm.2013.06.025
- https://doi.org//10.1126/Sciadv.abc7428
- https://doi.org//10.1016/j.cell.2020.05.015
- https://doi.org//10.1016/j.virol.2004.04.017
- https://doi.org//10.1128/JCM.42.11.5309-5314.2004
- https://doi.org//10.1016/j.jvacx.2020.100076
- https://doi.org//10.1093/nar/gkh424
- https://doi.org//10.21203/rs.3.rs-162289/v1
- https://doi.org//10.1186/s40425-019-0763-1
- https://doi.org//10.1111/tan.13811
- https://doi.org//10.1056/NEJMoa2022483
- https://doi.org//10.1016/j.medj.2021.04.003
- https://doi.org//10.1016/j.clim.2020.108426
- https://doi.org//10.1038/s41598-020-67749-1
- https://doi.org//10.1038/s41586-020-2550-z
- https://doi.org//10.1016/j.vaccine.2006.01.058
- https://doi.org//10.1093/annonc/mdz268.062
- https://doi.org//10.1016/j.humimm.2007.04.005
- https://doi.org//10.1038/s41586-020-03041-6
- https://doi.org//10.1002/jcp.29868
- https://doi.org//10.1038/s41590-020-00808-x
- https://doi.org//10.1128/JVI.00510-20
- https://doi.org//10.1016/j.eclinm.2020.100404
- https://doi.org//10.1146/annurev.iy.11.040193.001555
- https://doi.org//10.1016/S0140-6736%2820%2931976-0
- https://doi.org//10.1038/s41590-020-0782-6
- https://doi.org//10.1016/j.vaccine.2020.04.073
- https://doi.org//10.1101/2020.12.09.20245175
- https://doi.org//10.3201/2701.203772
- https://doi.org//10.1101/2020.06.29.174888
- https://doi.org//10.1101/2021.05.14.444076
- https://doi.org//10.1016/j.xcrm.2021.100204
- https://doi.org//10.1016/j.cell.2021.01.037
- https://doi.org//10.1200/JCO.2019.37.15_suppl.e14295
- https://doi.org//10.1016/j.clim.2020.108480
- https://doi.org//10.1038/s42003-021-01867-y
- https://doi.org//10.1016/j.cell.2020.09.015
- https://doi.org//10.1016/S2213-2600%2821%2900075-8
- https://doi.org//10.1371/journal.pone.0002636
- https://doi.org//10.1016/S1473-3099%2820%2930843-4
- https://doi.org//10.1128/JVI.01049-10
- https://doi.org//10.1056/NEJMc2001737
Usage metrics
Read the peer-reviewed publication
Categories
- Gene and Molecular Therapy
- Gene Expression (incl. Microarray and other genome-wide approaches)
- Genetics
- Genetically Modified Animals
- Livestock Cloning
- Developmental Genetics (incl. Sex Determination)
- Epigenetics (incl. Genome Methylation and Epigenomics)
- Biomarkers
- Genomics
- Genome Structure and Regulation
- Genetic Engineering
CC BY 4.0